+44 (0) 1223 755950
+1 832 327 7413
Orders to United States ship from United States
| Target | Eotaxin (CCL11) |
| Research Area | Infection Immunity, Autoimmunity |
| Origin | Human |
| Expression | Recombinant |
| Tested Applications | SDS-PAGE |
| Host | E. coli |
| Conjugation | Unconjugated |
| Form | Lyophilized |
| Biological Activity | The activity is determined by the chemoattract of human PBE (peripheral blood eosinophils) at a concentration between.1-1 ng/ml corresponding to a Specific Activity of 1,-1,,IU/mg. |
| Purity | > 97% (SDS-PAGE and RP-HPLC) |
| Reconstitution | It is recommended to reconstitute the lyophilized Eotaxin Human Recombinant in sterile 18MΩ-cm H2O not less than 100 µg/ml, which can then be further diluted to other aqueous solutions. |
| Storage | Store lyophilized at -18°C for long term storage. It is recommended to add a carrier protein (0.1% HSA or BSA). Upon reconstitution, store at 4°C for up to 1 week. Avoid repeated freeze/thaw cycles. |
| Shelf Life | 12 months. |
| UniProt Primary AC | P51671 (UniProt, ExPASy) |
| UniProt Secondary AC | P50877, Q92490, Q92491 |
| UniProt Entry Name | CCL11_HUMAN |
| KEGG | hsa:6356 |
| String | 9606.ENSP00000302234 |
| Sequence | The sequence of the first five N-terminal amino acids was determined and was found to be Gly-Pro-Ala-Ser-Val. |
| Availability | Shipped within 5-10 working days. |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |